17 / 68
UT I L I ZAT ION
HOSPI TALS
SANOFI / MANAGED CARE DIGEST SERIES
®
/
WHERE INFORMATION BECOMES INTELLIGENCE
.
™
HOSPITALS/SYSTEMS DIGEST 2015
15
Data source: IMS Health © 2015
Key Takeaway
Among the measures Medicare uses to rate Medicare Advantage plans—and determine
reimbursement—are readmission rates. Hence, health plans are likely to track the efficacy,
side-effects, adherence rates and other measures associated with various medications.
READMISSION RATES FOR PATIENTS DIAGNOSED WITH TYPE 2 DIABETES,
BY TYPE OF THERAPY, 2011–2013
1,2
Three-Day Readmissions
30-Day Readmissions
REGION
Any Insulin
Products Insulin Pens Insulin Vials
Three
Non-Insulin
Products
Any Insulin
Products Insulin Pens Insulin Vials
Three
Non-Insulin
Products
Mid-Atlantic
10.2% 7.7% 10.4% 13.9% 19.4% 16.1% 19.0% 25.0%
Midwest
9.4
5.5
9.6
11.4
19.4
15.2
19.4
21.6
Northeast
10.2
6.0
10.5
13.8
20.2
15.2
20.1
24.9
Pacific
8.4
6.8
8.2
11.7
16.5
15.5
15.5
22.0
Southeast
10.0
9.9
9.3
13.9
18.9
18.5
17.6
23.6
Southwest
9.7
11.8
7.2
14.8
17.9
19.6
14.8
24.7
NATION
9.9% 9.0% 9.3% 13.6% 18.9% 17.6% 17.8% 23.9%
1
Figures reflect the percentage of Type 2 diabetes patients who were readmitted to an inpatient facility in the three-year period between 2011
and 2013. These percentages include patients who filled multiple prescriptions. Readmissions are not necessarily due to Type 2 diabetes.
2
Patients who filled prescriptions for any insulin products may have also filled prescriptions for products in the non-insulin category, and vice versa.
3
Figures reflect the percentages of Type 2 diabetes patients who visited an emergency department between 2011 and 2013. These include
patients who filled multiple prescriptions.
PERCENTAGE OF TYPE 2 DIABETES PATIENTS WITH AT LEAST ONE EMERGENCY DEPARTMENT VISIT,
INSULIN PENS AND VIALS, 2011–2013
3
Mid-Atlantic Midwest
Northeast
Pacific
Southeast
Southwest
Nation
0%
7%
14%
21%
28%
Percentage of Patients
14.4%
19.9%
15.4%
23.2%
15.6%
16.8%
24.5%
19.1%
11.9%
14.1%
12.9%
19.2%
14.2%
16.8%
Insulin Pens
Insulin Vials
Readmit Rates Are Low for Type 2 Patients With Insulin Rxs
CHRONIC DISEASE
• From 2011 to 2013, readmission rates for Type 2
diabetes inpatients were lower in all regions
for those who received any insulin products
than for those on three non-insulin products.
• At the same time, three-day readmission rates
were lower for such patients on insulin pens than
for those on insulin vials in all but two regions.
This was true in three regions for 30-day rates.
LOCAL SPOTLIGHT
Likelihood of Emergency Department Visits Varies by Region and Type of Insulin Therapy
• From 2011 to 2013, Type 2 diabetes patients
who received insulin pens were less apt than
those who received vials to have at least one
emergency department (ED) visit in six regions.
• The Southeast region had the lowest
percentages of Type 2 diabetes patients
dispensed either insulin pens (11.9%) or insulin
vials (14.1%) who had at least one ED visit.